Preoperative [ 18 F]fluoro-PEG-folate PET/CT in advanced stage epithelial ovarian cancer: A safety and feasibility study.

MLA

Ciggaar, Isabeau A., et al. “Preoperative [ 18 F]Fluoro-PEG-Folate PET/CT in Advanced Stage Epithelial Ovarian Cancer: A Safety and Feasibility Study.” Nuclear Medicine and Biology, vol. 138–139, Nov. 2024, p. 108952. EBSCOhost, https://doi.org/10.1016/j.nucmedbio.2024.108952.

APA

Ciggaar, I. A., de Muynck, L. D. A. N., de Geus-Oei, L.-F., van Velden, F. H. P., de Kroon, C. D., Pereira Arias-Bouda, L. M., Noortman, W. A., van Persijn van Meerten, E. L., Dibbets-Schneider, P., Helmerhorst, H. J. F., Windhorst, A. D., Vahrmeijer, A. L., Peters, I. T. A., & Gaarenstroom, K. N. (2024). Preoperative [ 18 F]fluoro-PEG-folate PET/CT in advanced stage epithelial ovarian cancer: A safety and feasibility study. Nuclear Medicine and Biology, 138–139, 108952. https://doi.org/10.1016/j.nucmedbio.2024.108952

Chicago

Ciggaar, Isabeau A, Lysanne D A N de Muynck, Lioe-Fee de Geus-Oei, Floris H P van Velden, Cornelis D de Kroon, Lenka M Pereira Arias-Bouda, Wyanne A Noortman, et al. 2024. “Preoperative [ 18 F]Fluoro-PEG-Folate PET/CT in Advanced Stage Epithelial Ovarian Cancer: A Safety and Feasibility Study.” Nuclear Medicine and Biology 138–139 (November): 108952. doi:10.1016/j.nucmedbio.2024.108952.